Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspective
Morteza Abyadeh(Virginia Commonwealth University), Mehdi Mirzaei(AGRF Ltd), Yuyi You(Macquarie University), Nitin Chitranshi(Macquarie University), Vivek Gupta(Deakin University), Paul A. Haynes(Macquarie University), Danit Saks(AGRF Ltd), Roshana Vander Wall(Macquarie University), Matthew J. Fitzhenry(AGRF Ltd), Stuart L. Graham(The University of Sydney), Devaraj Basavarajappa(Macquarie University), Yunqi Wu(AGRF Ltd), Ghasem Hosseini Salekdeh(Macquarie University)
Cited by 49
Related Papers
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis
|The Lancet Public Health|2022|350
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
|EClinicalMedicine|2023|132
Amyloid-beta and tau protein beyond Alzheimer’s disease
|Neural Regeneration Research|2023|98